Graft-versus-host disease: Review of 22 cases;Maladie du greffon contre l'hôte: Revue de 22 cas

Acta Clinica Belgica

Volumn 59, Issue 4, 2004, Pages 182-188

  Steels, E ^a   Meuleman, N ^b   Vereecken, Pierre ^a,c,d,e   De Saint Aubain, N ^b   De Dobbeleer, G ^c   Bron, D ^b   Heenen, M ^c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b JULES BORDET INSTITUTE   (Belgium)

^c ERASME HOSPITAL   (Belgium)

^d CHU Andre Vesale   (Belgium)

^e NONE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; IDARUBICIN; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; THALIDOMIDE; THYMOCYTE ANTIBODY;

ACUTE DISEASE; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; BONE MARROW BIOPSY; CLINICAL FEATURE; DEATH; DIARRHEA; DISEASE ASSOCIATION; FEMALE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; MALE; MORBIDITY; MORTALITY; MUCOSA INFLAMMATION; PATHOPHYSIOLOGY; RELAPSE; REVIEW; SIDE EFFECT; SKIN DEFECT; THERAPY RESISTANCE;

EID: 8544262224     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2004.027     Document Type: Review

References (24)

1. Sullivan KM. Graft-Versus-Host Disease. In: Thomas ED, Blume KJ, Forman SJ. Haematopoietic cell transplantation. Blackwell Science, 1999: 515-536.
2. Bécherel PA, Chosidow O. Maladie du greffon contre l'hôte (GVH). Objectif peau 2000; 8-65:392-95.
3. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18:295-304.
4. Bron D. Graft-versus-host disease. Curr Opin Oncol 1994; 6: 358-64.
5. Ferrara JLM, Deeg HJ, Burakoff SJ. Graft-versus-host disease. M Dekker, Second Edition, 1997.
6. Maize JC. Cutaneous pathology. Churchill Livingstone, 1998: 110-113.
7. Aractingi S, Chosidow O. Cutaneous Graft-versus-Host disease. Arch Dermatol, 1998; 134:602-12.
8. Johnson ML, Farmer ER. Continuing Medical Education: Graft-versus-Host reactions in dermatology. J Am Acad Dermatol, 1998; 38-3:369-85.
9. Billingham RE. The biology of graft-versus-host reactions. Harvey Lect 1966-67; 62:21-78.
10. Nash RA, Pepe MS, Storb R, et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992; 80:1838-45.
11. Vogelsang B, Hess A, Berkman A, et al. An in vitro predictive test for graft versus host disease in patients with genotypic HLA identical bone marrow transplants. N Engl J Med 1985; 313: 645-50.
12. Theobald M, Nierle T, Bunjes D, Arnold R, Heimpel H. Host specific interleukin 2-secreting donor T-cell precursors as predictors of acute graft versus host disease in bone marrow transplantation between HLA identical siblings. N Engl J Med 1992; 327:1613-17.
13. Deeg HJ, Storb R. Clinical grading of acute GVHD. Ann Rev Med 1984; 35:11-24.
14. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15:825-8.
15. Storb R, Prentice RL, Buckner CD, et al. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med 1983; 308:302-7.
16. Horn TD, Zahurak ML, Atkins D, Solomon AR, Vogelsang GB. Lichen Planus-Like Histopathologic Characteristics in the Cutaneous Graft-vs-Host reaction. Arch Dermatol, 1997; 133: 961-5.
17. Marmont AM, Horowitz MM, Gale RP, et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78:2120-30.
18. Goldman JM, Gale RP, Horowitz MM, et al. Bone marrow transplantation for chronic myelogeneous leukemia in chronic phase: Increased risk of relapse associated with T-cell depletion. Ann Intern Med 1998; 108:806-14.
19. Lazarus HM, Vogelsang GB, Rowe JM. Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG). Bone Marrow Transplant 1997; 19(6):577-600.
20. Eppinger T, Emninger G, Steinert M, et al. 8-methoxypsoralen and UVA therapy for cutaneous GVHD. Transplantation 1990; 50:807-11.
21. Aubin F, Humbert P. Immunomodulation induced by psoralen plus ultraviolet A radiation. Eur J Dermatol 1998; 8(3):212-3.
22. Weisdorf D, Haake R, Blazar B, et al. Treatment of moderate-severe acute graft-versus-host disease after allogeneic bone marrow transplantation: An analysis of clinical risk features and outcome. Blood 1990; 75:1024-30.
23. Greinix HT, Volc-Platzer B, Knobler RM. Extra-corporeal photochemotherapy in the treatment of severe GVH disease. Leuk Lymphoma 2000; 36:425-34.
24. Greinix HT, Volc-Platzer B, Kalhs P, et al. Extra-corporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Blood 2000; 96(7):2426-31.